ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ATXI Avenue Therapeutics Inc

3.73
0.02 (0.54%)
After Hours
Last Updated: 17:52:39
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Avenue Therapeutics Inc ATXI NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.02 0.54% 3.73 17:52:39
Open Price Low Price High Price Close Price Prev Close
3.73 3.70 3.9899 3.73 3.71
more quote information »

Recent News

Date Time Source Heading
5/23/202408:30EDGAR2Form 8-K - Current report
5/16/202408:30GLOBEAvenue Therapeutics Announces Last Patient Last Visit in..
5/15/202409:01EDGAR2Form 8-K - Current report
5/15/202408:30GLOBEAvenue Therapeutics Reports First Quarter 2024 Financial..
5/13/202400:15EDGAR2Form EFFECT - Notice of Effectiveness
5/10/202416:53EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
5/10/202416:52EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
4/29/202408:00GLOBEAvenue Therapeutics Announces Exercise of Warrants for $4.4..
4/24/202407:30GLOBEAvenue Therapeutics Announces Reverse Stock Split
3/25/202408:30GLOBEAvenue Therapeutics to Host Virtual Key Opinion Leader (KOL)..
3/18/202416:05GLOBEAvenue Therapeutics Reports Full Year 2023 Financial Results..
3/15/202408:15GLOBEAvenue Therapeutics Receives Positive Listing Determination..
3/11/202408:00GLOBEAvenue Therapeutics to Present BAER-101 Preclinical Data at..
3/08/202416:31EDGAR2Form PRE 14C - Other preliminary information statements
3/08/202416:15EDGAR2Form 8-K - Current report
2/22/202408:30GLOBEAvenue Therapeutics Announces Publication in Drug..
1/29/202408:00EDGAR2Form DEF 14C - Other definitive information statements
1/24/202416:11EDGAR2Form S-3 - Registration statement under Securities Act of..
1/17/202417:05EDGAR2Form PRE 14C - Other preliminary information statements
1/12/202406:01EDGAR2Form 8-K - Current report
1/11/202408:00GLOBEAvenue Therapeutics to Present at Sidoti January Micro-Cap..
1/08/202417:28EDGAR2Form 8-K - Current report
1/05/202409:15GLOBEAvenue Therapeutics Enters into Warrant Exercise..
1/04/202408:30GLOBEAvenue Therapeutics Reaches Final Agreement with the U.S...
1/02/202408:30GLOBEAvenue Therapeutics Announces Completion of Enrollment in..
12/13/202316:03EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/13/202316:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/01/202308:30GLOBEAvenue Therapeutics to Present at American Epilepsy Society..
11/28/202316:05EDGAR2Form SC 13G - Statement of acquisition of beneficial..
11/28/202316:01EDGAR2Form 3 - Initial statement of beneficial ownership of..
11/24/202313:19EDGAR2Form 8-K - Current report
11/13/202316:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/13/202316:10EDGAR2Form 8-K - Current report
11/13/202316:05GLOBEAvenue Therapeutics Reports Third Quarter 2023 Financial..
11/02/202316:10EDGAR2Form 8-K - Current report
11/02/202315:00GLOBEAvenue Therapeutics Announces Closing of $5.0 Million Public..
11/02/202309:00EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
10/31/202309:15GLOBEAvenue Therapeutics Announces Pricing of $5.0 Million Public..
10/05/202317:05EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
9/29/202317:23EDGAR2Form S-1/A - General form for registration of securities..
9/28/202316:25EDGAR2Form 8-K - Current report
9/27/202316:03EDGAR2Form 8-K - Current report
9/18/202317:18EDGAR2Form S-1 - General form for registration of securities under..
9/08/202316:15EDGAR2Form 8-K - Current report
9/05/202308:30GLOBEAvenue Therapeutics to Present at H.C. Wainwright 25th..
8/14/202316:01GLOBEFortress Biotech Reports Second Quarter 2023 Financial..
8/11/202316:25EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/10/202316:20EDGAR2Form 8-K - Current report
8/10/202316:15GLOBEAvenue Therapeutics Reports Second Quarter 2023 Financial..
8/01/202308:30GLOBEAvenue Therapeutics Announces High Potency and Full Efficacy..

Your Recent History

Delayed Upgrade Clock